产后酮病奶牛血液生化指征分析

为了比较产后一段时期内酮病奶牛与健康奶牛血液生化指标的差异,为奶牛酮病的防控及兽医临床诊治提供理论依据。本研究选取吴忠市某集约化奶牛场待产奶牛共30头进行为期3周的血液生化指标监测,根据β-羟丁酸（BHBA）的浓度将奶牛分为酮病组和对照组并进行比较研究。结果显示,酮病组与对照组在生产当天（0 d）各项检测指标未出现显著性差异;酮病组奶牛β-羟丁酸浓度在产后7 d时较对照组极显著升高（P<0.01）;天门冬氨酸氨基转移酶（AST）和总胆红素（T-bil）浓度在产后7 d和14 d时显著升高（P<0.05）;血糖（Glu）浓度在产后7 d时显著降低（P<0.05）,产后14 d时极显著降低（P<0.01）;钙（Ca）、磷（P）浓度无显著性差异,但均低于正常参考值范围,出现低血钙、低血磷症。经分析发现,本场奶牛所患酮病为Ⅱ型酮病,酮病牛高发胎次为3~6胎,产后低血钙、低血磷、低血糖现象严重,同时奶牛酮病引发了机体肝脏功能损伤,影响母牛生产性能。     

奶牛血液保存条件和DNA提取方法的优化

本文研究中国荷斯坦牛血液在不同温度、时间保存的条件下（4℃保存0d为A组；-70℃保存30d为B组；4℃保存7d为C组）对DNA提取效果的影响和对比试剂盒法（E）、试剂盒改良法（F）、酚-氯仿法（G）提取中国荷斯坦牛血液基因组DNA的效果。试验结果表明：A组与B组差异不显著（P〉0．05）；A组、B组与C组差异显著（P〈0．05）。4℃保存0d对DNA提取效果影响最小。在A组中，E与F差异不显著（P〉0．05）；E、F与G差异显著（P〈0．05）。综合各方面因素。试剂盒改良法最好。     

Evaluation of a portable glucose meter for use in cattle and sheep

Background: In farm animal practice, determination of blood glucose concentration under field conditions is often necessary. Objective: As there is no portable glucose meter device developed for use in farm animals, the analytical accuracy of a portable glucometer designed for people was evaluated for its use in cattle and sheep. Methods: Blood samples from 90 cattle and 101 sheep were used in the study. Glucose concentration was determined in whole blood immediately after blood collection from the jugular vein with the One Touch Vita portable glucometer and in serum with an enzymatic colorimetric method. The agreement between methods was assessed by Passing and Bablok regression analysis. The precision and the accuracy of the measurements were determined using the concordance correlation coefficient. Results: There was a strong linear relationship between the glucose values obtained using the portable glucometer and those obtained by the bench method in both cattle and sheep. Precision was 95% for cattle and 88% for sheep, whereas accuracy was 92% and 99%, respectively. The mean glucose values obtained using the portable glucometer were significantly lower by 8.3% in cattle and 3.2% in sheep than those determined by the bench method. Conclusion: The One Touch Vita portable glucometer can be used in clinical practice to determine blood glucose concentrations in cattle and sheep, but reference intervals (RI) must be corrected to allow for negative bias. Based on these equations the RI for blood glucose in cattle and sheep using the portable glucometer were corrected to 1.84–4.17 and 2.41–4.35 mmol/L, respectively.     

Evaluation and Comparison of 2 On‐Farm Tests for Estimating Somatic Cell Count in Quarter Milk Samples from Lactating Dairy Cattle

Background

The somatic cell count (SCC) is commonly used to monitor udder health and diagnose subclinical intramammary infection (IMI) in dairy cattle.

Hypothesis

The Somaticell test (ST) 2 and California mastitis test (CMT) are clinically useful cow‐side tests for diagnosing subclinical IMI.

Animals

One hundred and eleven dairy cows at dry‐off and 92 cows within 4–7 days postcalving.

Methods

Quarter foremilk samples were obtained and analyzed with a DeLaval cell counter (DCC, reference method), 1 ST, and CMT. The ST was run in a simulated cow‐side manner using milk at 37°C instead of 0–8°C as recommended by the manufacturer. Test performance for diagnosing IMI (DCC SCC >200,000 cells/mL) was evaluated by calculating the area under the receiver operating characteristic curve (AUC) and the kappa coefficient (κ) at the optimal cut‐point for each test. The effect of milk/reagent temperature also was evaluated.

Results

Compared to the reference method, the ST run in a simulated cow‐side manner had an AUC = 0.68 and κ = 0.24 at dry‐off, and AUC = 0.74 and κ = 0.40 in fresh cows. The CMT performed much better than the ST in diagnosing subclinical IMI with AUC = 0.88 and κ = 0.77 at dry‐off, and AUC = 0.87 and κ = 0.76 in fresh cows. The measured ST value decreased with increasing temperature of the milk/reagent mixture.

Conclusions/Clinical Importance

The ST is optimized for use on milk at 0–8°C and is therefore designed for on‐farm use on refrigerated milk samples. The ST is not suited for use as a cow‐side screening test for IMI because the milk temperature exceeds the recommended range for the test.     

Evaluation of a Quality‐of‐Life Tool for Cats with Diabetes Mellitus

Background: Success in management of diabetes mellitus (DM) is defined as improvement of blood glucose concentrations and clinical signs. However, the psychological and social impact of DM and its daily treatment regimen on quality of life (QoL) of both animal and owner is uncertain. Hypothesis/Objectives: To design, validate, and apply a diabetic pet and owner‐centered, individualized measure of impact of DM (DIAQoL‐pet). Animals/Subjects: Two hundred and twenty‐one owners of insulin‐treated diabetic cats were recruited to complete the DIAQoL‐pet. Methods: Discussions and pilot surveys with clinicians and owners of diabetic cats led to the design of 29 specific DM‐associated QoL questions. Owners of diabetic cats completed the finalized survey. Each item was scored according to impact frequency and perceived importance. An item‐weighted impact score (IWIS) for each item was calculated, as was an average‐weighted impact score (AWIS) by averaging all IWISs. Principal component analysis and Cronbach's α calculation assessed the measure's reliability. Two overview questions measured overall QoL and diabetes‐dependent QoL. Results: The DIAQoL‐pet showed high reliability (Cronbach α 0.83). The AWIS was ?1.76 ± 2.4 (mean ± SD). Areas reported as most negatively impacting QoL included: “boarding difficulties” (IWIS ± SD: ?4.67 ± 5.3), “owner wanting more control” (?4.34 ± 4.7), “difficulties leaving cat with friends or family” (?4.21 ± 4.7), “worry” (?4.10 ± 3.9), “worry hypo” (?3.67 ± 3.5), “social life” (?3.48 ± 3.9), “costs” (?3.04 ± 3.8), and “work life” (?3.03 ± 3.7). Forty‐one percent of owners believed their cat's life would be “a little better” without DM. Conclusions and Clinical Importance: The DIAQoL‐pet proved robust and identified specific areas most negatively impacting on diabetic cats and their owners' QoL. This tool warrants further investigation for use in clinical or research settings.